Solventum (SOLV) Income from Continuing Operations (2023 - 2026)
Solventum's (SOLV) quarterly Income from Continuing Operations came in at 13000000.0 in Q1 2026, down 90.51% YoY from 137000000.0 in Q1 2025, and down 79.37% on a QoQ basis from 63000000.0 in Q4 2025.
Solventum (SOLV) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Solventum (SOLV) has 4 years of Income from Continuing Operations data on file, last reported at 13000000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 90.51% year-over-year to 13000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1432000000.0 (up 278.84% YoY) and the FY2025 annual result came in at 1556000000.0, up 225.52% from the prior year.
- Income from Continuing Operations declined to 13000000.0 in Q1 2026, from 63000000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 1266000000.0 in Q3 2025 to a low of 13000000.0 in Q1 2026.
- A 4-year average of 261000000.0 and a median of 137000000.0 in 2025 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations soared 937.7% — and 2026, when it plunged 90.51%.
- Tracing SOLV's Income from Continuing Operations over 4 years: stood at 272000000.0 in 2023, then tumbled by 88.97% to 30000000.0 in 2024, then soared by 110.0% to 63000000.0 in 2025, then tumbled by 79.37% to 13000000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 13000000.0 (Q1 2026), 63000000.0 (Q4 2025), and 1266000000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 452.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 135.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 108.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 63.00 Mn |
| Sep 30, 2025 | 1.27 Bn |
| Jun 30, 2025 | 90.00 Mn |
| Mar 31, 2025 | 137.00 Mn |
| Dec 31, 2024 | 30.00 Mn |
| Sep 30, 2024 | 122.00 Mn |
| Jun 30, 2024 | 89.00 Mn |
| Mar 31, 2024 | 237.00 Mn |
| Dec 31, 2023 | 272.00 Mn |
| Sep 30, 2023 | 460.00 Mn |
| Jun 30, 2023 | 321.00 Mn |
| Mar 31, 2023 | 293.00 Mn |